Naphthyl-,tetrahydronaphthyl-, and indanyl-substituted G-em-diphosphonates and process of use to treat hyperlipidemia
US5204336A · kind A · utility
1Cited by
0References
43Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 1992 |
| Grant date | Apr 20, 1993 |
| Priority date | — |
| Expiry date | May 6, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/404
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Substituted gem-diphosphonate compounds having use as cholesterol lowering agents are disclosed. A compound of the invention is tetraethyl-2-[3-t-butyl-4-hydroxynaphthyl]ethenylidene-1,1-diphosphonate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.